The Physical and Psychosocial Impact of Fatigue among Patients with Sjogren's Syndrome: A Systematic Review
- PMID: 38541763
- PMCID: PMC10971331
- DOI: 10.3390/jcm13061537
The Physical and Psychosocial Impact of Fatigue among Patients with Sjogren's Syndrome: A Systematic Review
Abstract
Background: Primary Sjögren's syndrome (pSS) is a complex autoimmune disorder characterized by organ-specific symptoms in the salivary and lacrimal glands, as well as systemic manifestations. Fatigue, a prominent aspect, significantly influences the overall quality of life for individuals with pSS. Methods: This review seeks to evaluate the impact of fatigue by exploring its consequences, potential causes, and effects on physical and psychological well-being, while also investigating its management strategies. Following the "Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)" guidelines, our systematic literature review involved a five-step algorithm. Initially identifying 78 articles in reputable international medical databases, we applied eligibility criteria and removed duplicates, resulting in 19 articles for qualitative synthesis. Results: This review delves into the predictive factors for heightened fatigue in pSS, encompassing rheumatoid factor levels, erythrocyte sedimentation rate, and immunoglobulin G levels. Sleep disturbances, specifically nighttime pain and nocturia, emerged as determinants of persistent daytime fatigue. Cognitive impairment in pSS involves deteriorations in global memory, executive functioning, and attentional resources. Furthermore, functional limitations in pSS impact patients' quality of life. Conclusions: The significance of fatigue in pSS, its consequences, and profound influence on the quality of life necessitate further research for a more comprehensive understanding of this complex issue.
Keywords: cognitive concerns; fatigue; predictive factors; primary Sjogren’s syndrome; sleep disturbance.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Cognitive Function in Primary Sjögren's Syndrome: A Systematic Review.Brain Sci. 2019 Apr 15;9(4):85. doi: 10.3390/brainsci9040085. Brain Sci. 2019. PMID: 30991679 Free PMC article.
-
Validation of the PROFAD-SSI-SF in Patients with Primary Sjögren's Syndrome with Organ Involvement: Results of Qualitative Interviews and Psychometric Analyses.Rheumatol Ther. 2023 Feb;10(1):95-115. doi: 10.1007/s40744-022-00493-2. Epub 2022 Oct 13. Rheumatol Ther. 2023. PMID: 36227531 Free PMC article.
-
CXCL9 may serve as a potential biomarker for primary Sjögren's syndrome with extra-glandular manifestations.Arthritis Res Ther. 2024 Jan 17;26(1):26. doi: 10.1186/s13075-023-03229-x. Arthritis Res Ther. 2024. PMID: 38229121 Free PMC article.
-
Understanding Fatigue in Sjögren's Syndrome: Outcome Measures, Biomarkers and Possible Interventions.Front Immunol. 2021 Jun 25;12:703079. doi: 10.3389/fimmu.2021.703079. eCollection 2021. Front Immunol. 2021. PMID: 34249008 Free PMC article. Review.
-
Effectiveness and Safety of Iguratimod in Treating Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.Front Pharmacol. 2021 Mar 19;12:621208. doi: 10.3389/fphar.2021.621208. eCollection 2021. Front Pharmacol. 2021. PMID: 33815105 Free PMC article. Review.
Cited by
-
FatiguE in Sjögren's Syndrome: a randomised controlled trial of cOmbined Non-phArmacological therapeutic strategies (FESSONA).BMJ Open Sport Exerc Med. 2025 Jun 16;11(2):e002677. doi: 10.1136/bmjsem-2025-002677. eCollection 2025. BMJ Open Sport Exerc Med. 2025. PMID: 40546749 Free PMC article.
-
A pragmatic double blind remote pilot feasibility randomised controlled trial of a self-management app for people with Sjögren disease.Front Digit Health. 2025 Jun 3;7:1549093. doi: 10.3389/fdgth.2025.1549093. eCollection 2025. Front Digit Health. 2025. PMID: 40529607 Free PMC article.
References
-
- Brito-Zerón P., Kostov B., Solans R., Fraile G., Suárez-Cuervo C., Casanovas A., Rascón F.J., Qanneta R., Pérez-Alvarez R., Ripoll M., et al. Systemic activity and mortality in primary Sjögren syndrome: Predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients. Ann. Rheum. Dis. 2016;75:348–355. doi: 10.1136/annrheumdis-2014-206418. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources